HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 80 filers reported holding HARPOON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $263,234 | -17.1% | 370,753 | -13.1% | 0.00% | – |
| Q1 2023 | $317,615 | -24.7% | 426,786 | -26.5% | 0.00% | – |
| Q4 2022 | $421,576 | -52.4% | 580,923 | -36.4% | 0.00% | – |
| Q3 2022 | $886,000 | -50.7% | 913,947 | -2.8% | 0.00% | – |
| Q2 2022 | $1,797,000 | -80.0% | 940,475 | -48.0% | 0.00% | – |
| Q1 2022 | $8,994,000 | -30.5% | 1,809,686 | +5.6% | 0.00% | – |
| Q4 2021 | $12,944,000 | -5.5% | 1,714,331 | -1.1% | 0.00% | – |
| Q3 2021 | $13,691,000 | -42.4% | 1,733,182 | +1.2% | 0.00% | -100.0% |
| Q2 2021 | $23,765,000 | -31.9% | 1,713,296 | +2.7% | 0.00% | 0.0% |
| Q1 2021 | $34,885,000 | +54.0% | 1,667,551 | +22.2% | 0.00% | 0.0% |
| Q4 2020 | $22,659,000 | +17.6% | 1,364,212 | +20.3% | 0.00% | 0.0% |
| Q3 2020 | $19,267,000 | +15.9% | 1,133,972 | +13.3% | 0.00% | 0.0% |
| Q2 2020 | $16,620,000 | +78.7% | 1,001,115 | +24.6% | 0.00% | – |
| Q1 2020 | $9,303,000 | +37.7% | 803,467 | +75.9% | 0.00% | – |
| Q4 2019 | $6,756,000 | +53.7% | 456,832 | +41.9% | 0.00% | – |
| Q3 2019 | $4,397,000 | +15.0% | 321,992 | +9.5% | 0.00% | – |
| Q2 2019 | $3,824,000 | +335.0% | 294,047 | +216.8% | 0.00% | – |
| Q1 2019 | $879,000 | – | 92,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |